Skip to main content
Equibles

Trexquant Investment LP

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1633445 STAMFORD, CT
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,770,888
+$376,887 QoQ
Shares Held
152,163
-9.7% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#52
of 183 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $612,941,942 across 144 Biotechnology names. CGEM ranks #63 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 505,160 $35,376,354
2 TWST
Twist Bioscience Corp
 255,271 $26,262,280
3 REGN
Regeneron Pharmaceuticals, Inc.
 41,839 $26,088,290
4 RVMD
Revolution Medicines, Inc.
 120,122 $22,496,448
5 AXSM
Axsome Therapeutics, Inc.
 83,679 $20,482,108
6 RARE
Ultragenyx Pharmaceutical Inc.
 556,385 $18,577,695
7 INSM
INSMED Inc
 156,553 $16,691,680
8 SRRK
Scholar Rock Holding Corp
 275,712 $15,164,160

All Filings in CGEM

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,770,888 152,163
2026-03-31 $2,394,001 168,473
2025-12-31 $3,948,887 381,535
2025-09-30 $1,112,574 187,618
2025-06-30 $898,645 119,342
2025-03-31 $518,295 68,467
2023-12-31 $356,191 34,955
2022-12-31 $108,126 10,249
2022-09-30 $303,282 23,657
2022-06-30 $408,329 31,851